In the largest real-world analysis of U.S. patients, researchers used insurance claims data to study the effectiveness of five drugs known as tyrosine kinase inhibitors to better understand differences in how the drugs affect patient outcomes.
“Somewhere out there right now, there is a patient who is going to live longer, live better, or live at all, because of what you all will accomplish.” —Biopharmaceutical industry executive David Meek, USC Mann Board of Councilors
Tiffany Yarian, PharmD ’26, will begin a two-year oncology medical affairs fellowship in June, capping four years of industry-focused training at USC Mann.
Graduating in just three years, Elizabeth “Ellie” Zuniga heads into USC Mann’s PharmD program with a passion for patient education and serving others with empathy.
From Burkina Faso, West Africa, to Pfizer’s U.S. Vaccines Strategy Team, Rahinatou Sawadogo has charted a career path at the intersection of biopharmaceutical science and business.
Makenna Fox, PharmD ’26, will become the first resident in the school’s new PGY-1 geriatrics pharmacy residency program—an early step toward addressing the growing need for specialized care for older adults.
The 2026 USC Mann PharmD Student Awards Ceremony on Thursday, April 30 brought together families, students, and friends to recognize students for their exceptional achievements.
